Immunex has issued a release stating they are initiating phase I trials for a NHL drug. They also have recieved some positive TV news coverage of a treatment for rhumatoid arthritis (did I spell that right?) to be ready for market in a year if approved. This is competition for IDEC and could be affecting the stock price. Immunex is up about 2 1/2 today.